Table 1.
Women's satisfaction with a shared decision‐making tool for use in perinatal opioid use disorder a
| Survey question | IPDASi domain | Agree or strongly agree | |
|---|---|---|---|
| N | % | ||
| I was provided with enough information to make an informed treatment choice. | Information | 20 | 91 |
| I understood the medical information provided about my treatment choices. | Information | 21 | 96 |
| My provider discussed and provided medical information to support statements about my treatment choices. | Evidence | 20 | 91 |
| I understood the risk to me, my pregnancy, and newborn with taking medication such as buprenorphine or methadone during pregnancy. | Evidence and probability | 20 | 91 |
| I understood the risk to me, my pregnancy, and newborn with not taking medication such as buprenorphine or methadone during pregnancy. | Evidence and probability | 20 | 91 |
| My treatment choice supported my values. | Values | 17 | 77 |
| My treatment choice supported my preferences. | Values | 20 | 91 |
| I was able to discuss which treatment choice was right for me. | Values | 19 | 86 |
| I was able to weight the pros [positives] and cons [negatives] of treatment choices. | Decision guidance | 20 | 91 |
| I felt that the treatment choices were made in partnership with my provider. | Decision guidance | 19 | 86 |
| I made a decision to either continue or discontinue my methadone or buprenorphine. | Decisional conflict | 21 | 95 |
| The developers of the decision aid were clear and disclosed during the decision‐making process. | Disclosure | 21 | 95 |
a
IPDASi, International Patient Decision Aid Standards Instrument. Survey responses were anonymous.